J A Kemp - Concepedia

Author

J A Kemp

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

J A Kemp, J KEMP, J. A. KEMP, J. A. Kemp, J.A. Kemp, JA Kemp, John A. Kemp, Kemp, J.A.

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)MSD (UK) Limited (United Kingdom)Royal Veterinary College

About

J A Kemp is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	2.2K
2	Social Sciences	4	4	2.1K
3	Biochemistry	2	2	140
4	Health Sciences	1	1	100
5	Natural Sciences	1	1	13

J A Kemp

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Erik H.F. Wong, J A Kemp, Tony Priestley, Proceedings of the National Academy of Sciences Mk-801 Binding SitesNeurotransmitterPsychopharmacologyPharmacotherapySocial Sciences	1986	1.8K
Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors. Karen L. Hadingham, Peter B. Wingrove, Keith A. Wafford, Molecular Pharmacology	1993	201
Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. Bjarke Ebert, Keith A. Wafford, Paul J. Whiting, Molecular Pharmacology	1994	176
Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. Keith A. Wafford, Paul J. Whiting, J A Kemp Molecular Pharmacology	1993	154
Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors. Keith A. Wafford, C Bain, Paul J. Whiting, Molecular Pharmacology	1993	147
The neuroprotective action of dizocilpine (MK‐801) in the rat middle cerebral artery occlusion model of focal ischaemia R. Gill, C. Brazell, G.N. Woodruff, British Journal of Pharmacology Focal IschaemiaPharmacotherapySocial SciencesCerebral Vascular RegulationThrombosis	1991	130
HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site AC Foster, J A Kemp Journal of Neuroscience NeurotransmitterHa-966 Blocks NmdaNeurotransmissionSocial SciencesGlycine Modulatory Site	1989	127
The effect of ω‐conotoxin GVIA on synaptic transmission within the nucleus accumbens and hippocampus of the rat <i>in vitro</i> A.L. Horne, J A Kemp British Journal of Pharmacology Calcium EntryL-channel Antagonist NisoldipineSynaptic TransmissionNeurotransmitterNeurotransmission	1991	100
2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the N-methyl-D-aspartate (NMDA) receptor Robert W. Carling, P D Leeson, Angela M. Moseley, Journal of Medicinal Chemistry	1992	100
The Neuroprotective Effect of the Glycine Site Antagonist 3<i>R</i>-(+)-<i>cis</i>-4-Methyl-HA966 (L-687,414) in a Rat Model of Focal Ischaemia R. Gill, Richard Hargreaves, J A Kemp Journal of Cerebral Blood Flow & Metabolism	1995	48

Page 1